Quick Takeaways
- GILEAD SCIENCES, INC. filed SCHEDULE 13G/A for CYPHERPUNK TECHNOLOGIES INC. Common Stock, par value $0.001 per share (CYPH).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2025.
GILEAD SCIENCES, INC. - 31 Dec 2025 SCHEDULE 13G/A Report for CYPHERPUNK TECHNOLOGIES INC. Common Stock, par value $0.001 per share (CYPH)
- Filing Manager
- GILEAD SCIENCES, INC.
- Reporting Manager
- GILEAD SCIENCES, INC.
- Symbol
- CYPH
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2026, 16:35:04 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GILEAD SCIENCES, INC. disclosed 0% ownership in CYPHERPUNK TECHNOLOGIES INC. Common Stock, par value $0.001 per share (CYPH) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2026, 16:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 0% | 0 | 0 | 0 | /s/ Andrew D. Dickinson | Andrew D. Dickinson, Executive Vice President and Chief Financial Officer |